1.4(top 50%)
impact factor
199(top 50%)
papers
3.8K(top 20%)
citations
33(top 20%)
h-index
1.6(top 50%)
extended IF
206
all documents
4.0K
doc citations
50(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Meta-Analysis of Three Different Types of Fatigue Management Interventions for People with Multiple Sclerosis: Exercise, Education, and MedicationMultiple Sclerosis International2014159
2DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical ImplicationsMultiple Sclerosis International2013118
3Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence TomographyMultiple Sclerosis International2012113
4The Contribution of Immune and Glial Cell Types in Experimental Autoimmune Encephalomyelitis and Multiple SclerosisMultiple Sclerosis International201485
5Measuring the Quality of Life in Patients with Multiple Sclerosis in Clinical Practice: A Necessary ChallengeMultiple Sclerosis International201381
6Plasma Exchange in Severe Attacks of Neuromyelitis OpticaMultiple Sclerosis International201277
7Biomarkers in Multiple Sclerosis: An Up-to-Date OverviewMultiple Sclerosis International201376
8Brain Abnormalities in Neuromyelitis Optica Spectrum DisorderMultiple Sclerosis International201271
9Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-AnalysisMultiple Sclerosis International201569
10Correlations between MRI and Information Processing Speed in MS: A Meta-AnalysisMultiple Sclerosis International201467
11Activities-Specific Balance Confidence in People with Multiple SclerosisMultiple Sclerosis International201266
12Gait Variability and Multiple SclerosisMultiple Sclerosis International201363
13Serum Metabolic Profile in Multiple Sclerosis PatientsMultiple Sclerosis International201162
14Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled TrialMultiple Sclerosis International201260
15Adding to the Burden: Gastrointestinal Symptoms and Syndromes in Multiple SclerosisMultiple Sclerosis International201360
16Ultrahigh-Field MR (7 T) Imaging of Brain Lesions in Neuromyelitis OpticaMultiple Sclerosis International201357
17Internet Usage by Patients with Multiple Sclerosis: Implications to Participatory Medicine and Personalized HealthcareMultiple Sclerosis International201056
18The Impact of Comorbid Depression on Adherence to Therapy for Multiple SclerosisMultiple Sclerosis International201155
19The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple SclerosisMultiple Sclerosis International201555
20Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical TrialsMultiple Sclerosis International201454
21Treadmill Training in Multiple Sclerosis: Can Body Weight Support or Robot Assistance Provide Added Value? A Systematic ReviewMultiple Sclerosis International201253
22Predicting Falls in People with Multiple Sclerosis: Fall History Is as Accurate as More Complex MeasuresMultiple Sclerosis International201346
23Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRIMultiple Sclerosis International201446
24Spatial Analysis of Global Prevalence of Multiple Sclerosis Suggests Need for an Updated Prevalence ScaleMultiple Sclerosis International201444
25Stride-Time Variability and Fall Risk in Persons with Multiple SclerosisMultiple Sclerosis International201544
26Iron and Neurodegeneration in Multiple SclerosisMultiple Sclerosis International201140
27Optical Coherence Tomography in Multiple Sclerosis and Neuromyelitis Optica: An UpdateMultiple Sclerosis International201140
28Neurofilament Proteins as Body Fluid Biomarkers of Neurodegeneration in Multiple SclerosisMultiple Sclerosis International201139
29The Clinical Relevance of Force Platform Measures in Multiple Sclerosis: A ReviewMultiple Sclerosis International201339
30Fatigue, Tiredness, Lack of Energy, and Sleepiness in Multiple Sclerosis Patients Referred for Clinical PolysomnographyMultiple Sclerosis International201238
31Assessment of Definitions of Sustained Disease Progression in Relapsing-Remitting Multiple SclerosisMultiple Sclerosis International201338
32Quantitative Magnetic Resonance Imaging of Cortical Multiple Sclerosis PathologyMultiple Sclerosis International201236
33Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical TrialsMultiple Sclerosis International201535
34Intrathecal IgG Synthesis: A Resistant and Valuable Target for Future Multiple Sclerosis TreatmentsMultiple Sclerosis International201535
35The Role of Wearable Devices in Multiple SclerosisMultiple Sclerosis International201835
36Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated EntitiesMultiple Sclerosis International201534
37Hyperacute Corticosteroid Treatment of Optic Neuritis at the Onset of Pain May Prevent Visual Loss: A Case SeriesMultiple Sclerosis International201133
38Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient SurveyMultiple Sclerosis International201433
39Induced Brain Plasticity after a Facilitation Programme for Autobiographical Memory in Multiple Sclerosis: A Preliminary StudyMultiple Sclerosis International201231
40Infodemiology and Infoveillance of Multiple Sclerosis in ItalyMultiple Sclerosis International201330
41Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus RisksMultiple Sclerosis International201630
42Potential Impact of B Cells on T Cell Function in Multiple SclerosisMultiple Sclerosis International201128
43Gray Matter Pathology in MS: Neuroimaging and Clinical CorrelationsMultiple Sclerosis International201328
44The Effect of Community Exercise Interventions for People with MS Who Use Bilateral Support for GaitMultiple Sclerosis International201428
45Evaluating the Use of Optical Coherence Tomography in Optic NeuritisMultiple Sclerosis International201127
46Falls and Physical Activity in Persons with Multiple SclerosisMultiple Sclerosis International201227
47Fatigue and Sleep-Disordered Breathing in Multiple Sclerosis: A Clinically Relevant Association?Multiple Sclerosis International201327
48Management of Multiple Sclerosis in the Breastfeeding MotherMultiple Sclerosis International201627
49Autoimmune T-Cell Reactivity to Myelin Proteolipids and Glycolipids in Multiple SclerosisMultiple Sclerosis International201326
50The Evidence for Hypoperfusion as a Factor in Multiple Sclerosis Lesion DevelopmentMultiple Sclerosis International201325